Skip to content

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00171665
Enrollment
360
Registered
2005-09-15
Start date
2005-05-31
Completion date
2005-12-31
Last updated
2015-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Hand osteoarthritis, Topical NSAID, Diclofenac sodium

Brief summary

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis.

Interventions

Sponsors

Novartis
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion criteria: • Osteoarthritis of the hand Key

Exclusion criteria

* Other rheumatic disease, such as rheumatoid arthritis * Active gastrointestinal ulcer during the last year * Known allergy to analgesic drugs

Design outcomes

Primary

MeasureTime frame
OA pain intensity in target hand at Week 4 and 6
Total AUSCAN score in target hand at Week 4 and 6
Global rating of disease activity by patient at Week 4 and 6

Secondary

MeasureTime frame
Global evaluation of treatment at final visit
OA pain intensity and total AUSCAN score in target hand, and global rating of disease activity by patient at Weeks 1, 2 and 8
Treatment responder rate according to OARSI criteria
AUSCAN pain, stiffness and physical function scores in target hand, and global rating of benefit by patient at Weeks 1, 2, 4, 6 and 8
OA pain intensity in target hand and use of rescue medication recorded in diary

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026